US2016184292A1PendingUtilityA1

Sublingual and buccal film compositions

56
Assignee: MONOSOL RX LLCPriority: Aug 7, 2009Filed: Jul 30, 2015Published: Jun 30, 2016
Est. expiryAug 7, 2029(~3.1 yrs left)· nominal 20-yr term from priority
A61P 25/04A61K 47/12A61K 9/7007A61K 47/10A61K 31/485A61K 9/0056A61K 9/006
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to products and methods for treatment of various symptoms in a patient, including treatment of pain suffered by a patient. The invention more particularly relates to self-supporting dosage forms which provide an active agent while providing sufficient buccal adhesion of the dosage form. Further, the present invention provides a dosage form which is useful in reducing the likelihood of diversion abuse of the active agent.

Claims

exact text as granted — not AI-modified
1 .- 65 . (canceled) 
     
     
         66 . A self-supporting film dosage composition comprising:
 a. A polymeric carrier matrix;   b. A therapeutically effective amount of an agonist or a pharmaceutically acceptable salt thereof; and   c. a buffer sufficient to optimize the absorption of the agonist, wherein said buffer provides a pH of from about 2 to about 3.5 in the presence of saliva.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.